Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme and proteasome protein expression in KKAy mice
JDS-CRI-003 (CRI) is a novel form of insulin that has been directly conjugated with chromium (Cr) instead of zinc. Our hypothesis was that CRI enhances insulin’s effects by altering insulin degrading enzyme (IDE) and proteasome enzymes. To test this hypothesis, we measured hepatic IDE content and p...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Frontiers Media S.A.
2014-07-01
|
| মালা: | Frontiers in Endocrinology |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00099/full |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|